Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

NonSegmental Vitiligo

Tundra lists 5 NonSegmental Vitiligo clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT06113471

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-31

18 states

NonSegmental Vitiligo
ACTIVE NOT RECRUITING

NCT06113445

A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-23

19 states

NonSegmental Vitiligo
RECRUITING

NCT07437560

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-02-27

1 state

NonSegmental Vitiligo
Nonsegmental Vitiligo (Stable)
RECRUITING

NCT06548360

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.

Gender: All

Ages: 2 Years - 11 Years

Updated: 2025-12-18

36 states

NonSegmental Vitiligo
RECRUITING

NCT06804811

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in children (6 to \< 12 years old) with nonsegmental vitiligo.

Gender: All

Ages: 6 Years - 11 Years

Updated: 2025-12-17

NonSegmental Vitiligo